Navigation Links
Haymarket Adds Two Cancer Journals to Its Family of Clinical Publications
Date:3/21/2008

NEW YORK, March 21 /PRNewswire/ -- Haymarket Media Inc. is now the publisher of two leading journals for cancer clinicians, The American Journal of Hematology/Oncology and Oncology Nursing News, under an agreement announced today. Both titles were previously published by U.S. HealthCare Communications, of Highland Park, NJ.

"We are very pleased to add a strong oncology presence to the Haymarket clinical family," said Lee Maniscalco, CEO. "The practical, clinical guidance these publications offer to their readers, and the wide variety of Continuing Education opportunities they provide throughout the year -- within the journals themselves, in special supplements, and in Web-based initiatives -- make this a perfect fit for Haymarket. The addition of these two publications is entirely consistent with our goal of expanding and enhancing learning opportunities for practicing cancer clinicians nationwide."

The American Journal of Hematology/Oncology (AJHO) reaches oncologists, hematologists, and other cancer clinicians nationwide. Each monthly issue offers concise summaries and expert commentaries on the peer-reviewed scientific literature and conference proceedings, so that the latest research findings can be applied in day-to-day patient care. The editorial board is headed by Lawrence N. Shulman, MD, Chief Medical Officer, Dana Farber Cancer Institute, and Associate Professor of Medicine, Harvard Medical School, Boston; and Douglas J. Schwartzentruber, MD, Medical Director of the Goshen Center for Cancer Care, Goshen, Indiana. Marcus E. Randall, MD, Professor and Chair of Radiation Medicine at the University of Kentucky School of Medicine, Lexington, serves AJHO as Associate Editor for Radiation Oncology. Each issue of the journal offers Continuing Medical Education accredited by Harvard Medical School.

Oncology Nursing News (ONN) provides late-breaking clinical news and practical guidance to nurses, nurse practitioners, and physician assistan
'/>"/>

SOURCE Haymarket Media Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)..., PALO ALTO, Calif., Dec. 4 /PRNewswire-FirstCa...nced today that its Board of Directors has set the...ebruary 11, 2010 with a record date of December 16...za Cabana Hotel, 4290 El Camino Real, Palo Alto, C...be webcast by Thomson Financial and can be accesse...
(Date:12/4/2009)...YORK, Dec. 4 Care Inves...ompany") today announced that its Board of Directo...ommon stock. The dividend is payable on December ...ber 14, 2009. ,, About Care Investment Trus...te investment and finance company investing in hea...
(Date:12/4/2009)...EW YORK, Dec. 4 Thousands of KPMG ...s nationwide today, to participate in a community ...visory firm,s support for literacy with charitable...s our firm,s long history of volunteerism. Instead... spirit of caring to brighten the holidays for som...
(Date:12/4/2009)...N FRANCISCO, Dec. 4 Medithrive, In...ite dispensary in the SF Bay Area by popular vote .... Despite only three months in operation, the SF ...inent location for accessing medicinal marijuana. ...e confirms the obvious: a dispensary which caters ...
(Date:12/4/2009)... PEMBROKE, Bermuda, Dec. 4 /PRNewswire-FirstCall...(NYSE: AWH ) today announced that Scott Carmilan... Sennott, Executive Vice,President and Chief Corpo...009,Goldman Sachs U.S. Financial Services Conferen...er in New York City on Tuesday, December 8, 2009. ...
Breaking Medicine News(10 mins):Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2
...arch presented at Digestive Disease Week 2005, ant...l bleedings. Clinical depression, also known ...depressant drugs like selective serotonin reuptake...leeding and hemorrhage in gastro intestinal tracts...
...rom Wake Forest University Baptist Medical Center,...orks equally well for children with cancer, and th... The researchers had looked into the chemothe...ery limited dosage of chemotherapy and were monito...
...ering from Attention Deficit Hyperactivity Syndrom...n with the help of sensory interventions like appl...us exercise, etc. Attention Deficit Hyperacti...to be impulsive, inattentive and hyperactive. Rece...
...ave identified a virus that targets and kills a ty...omatitis virus (VSV) can successfully target and k...rms of brain tumors. Glioblastoma is a form of bra...viruses through a series of tests to find out the ...
...rom Netherlands have found out that certain ordina...l drugs can cause deaths from cardiac arrest. ...n Heart Journal, said that the non-cardiac drugs i...rolong the duration of electrical activity that co...
... report done by Swedish scientists its said that i...ge of prostate cancer than to wait and see if the ...tate cancer, also known as prostatectomy, is a com...watching and waiting the cancer in the prostate gl...
Other Medicine News:
(Date:12/4/2009)...RISTOWN, N.J., Dec. 4 Wa...ng global specialty pharmaceutical company, today ..., Inc.-Florida, filed an Abbreviated New Drug Appl...tration seeking approval to market its 8mg ramelte...ed by Takeda Pharmaceutical Company Limited. Wats...
(Date:12/4/2009)...SDA, Md., Dec. 4 Drs. Neal Shore a...e-specific antigen (PSA) recurrence from the addit...cal recurrence rate in a Phase III pivotal study o... or monthly leuprolide in prostate cancer patients...cer patients who received FIRMAGON 240/80 mg/month...
(Date:12/4/2009)...INGTON, Del., Dec. 4 Ast...S Food and Drug Administration (FDA) has approved ... Extended Release Tablets as adjunctive (add-on) t...epressive Disorder (MDD). SEROQUEL XR is the only ...at both major depressive disorder as adjunctive th...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Price Chopper Supermarkets Deploy Micromedex Solutions From Thomson Reuters as Key Component of Its Patient Centered Care Initiatives 53960 1Price Chopper Supermarkets Deploy Micromedex Solutions From Thomson Reuters as Key Component of Its Patient Centered Care Initiatives 53960 2Steroid Can Ease Severe Sore Throat 53956 1Steroid Can Ease Severe Sore Throat 53956 2Steroid Can Ease Severe Sore Throat 53956 3Allscripts Notified of Purported Class Action Lawsuit 53952 1Allscripts Notified of Purported Class Action Lawsuit 53952 2Allscripts Notified of Purported Class Action Lawsuit 53952 3
...ells Inc. (BCI), a,biopharmaceutical company utili...op compounds that promote the growth of new neuron...) diseases, announced today that it has,initiated ...ndidate,BCI-540, for the treatment of depression w...m expressed by our clinical,investigators who view...
...f Company,s Phase 3 Study for Wet AMD after ...ONT, Calif., April 17 NeoVista, Inc. announced,to...A) has granted the,company,s request to expand the...e 3 trial from 10 to 30 in the United States. The ...MD Treated with BEta RadiatioN,Epiretinal Therapy)...
Other Medicine Technology:BrainCells Inc. Initiates Phase 2 Clinical Trial with BCI-540 for Depression with Anxiety 2FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S. 2FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S. 3
Tumbling E Pad(100 sheets) BCE
...riced 2-channel data acquisition system suitable f...n and animal physiology, pharmacology, neurophysio...l engineering. The PowerLab 2/25 supports all ADIn... Pod ports are featured allowing direct connection...
... data acquisition system suitable for a wide range...al physiology, pharmacology, neurophysiology, biol...ring. The unit is capable of recording from very s... second continuously to disk), and is compatible w...
Worth 4 Dot Test
Medicine Products: